Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parapneumonic effusion and empyema

H Hamm1, R W Light

  • 1Abt. Pneumologie, Medizinische Universitätsklinik, Freiburg, Germany.

The European Respiratory Journal
|May 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of fumaric acid esters in young patients aged 10-17 years with moderate-to-severe plaque psoriasis: a randomized, double-blinded, placebo-controlled trial.

The British journal of dermatology·2020
Same author

[Pigmented macules as possible early signs of genetic syndromes].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

Successful factor XIII treatment of refractory chylothorax in tuberous sclerosis complex-associated lymphangioleiomyomatosis, multifocal multinodular pneumocyte hyperplasia and mediastinal lymphadenopathy.

Lymphology·2018
Same author

[Lichen nitidus and lichen striatus].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017
Same author

[Slate-gray macules in the axillae].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2017
Same author

Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).

Canadian respiratory journal·2017
Same journal

Beyond the 5th percentile: rethinking diagnostic thresholds in pulmonary function testing.

The European respiratory journal·2026
Same journal

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same journal

Risk of cancer and mortality in patients with interstitial lung diseases: Danish cohort study.

The European respiratory journal·2026
Same journal

Proposing a minimal important difference in NTproBNP in pulmonary arterial hypertension.

The European respiratory journal·2026
Same journal

Unlocking growth potential: Ivacaftor therapy and developmental gains in lung and height in a cohort study of children and young adults with cystic fibrosis.

The European respiratory journal·2026
Same journal

Decoding the Lymphangioleiomyomatosis (LAM) Niche Microenvironment <i>via</i> Integrative Analysis of Single Cell Multiomics and Spatial Transcriptomics.

The European respiratory journal·2026
See all related articles

Parapneumonic effusions, fluid around the lungs due to pneumonia, require staging for appropriate treatment. Early diagnosis and tailored therapy for these pleural effusions improve patient outcomes.

Area of Science:

  • Pulmonology
  • Thoracic Medicine

Background:

  • Parapneumonic effusions are common complications of pneumonia, affecting approximately 40% of patients.
  • These effusions are linked to increased patient morbidity and mortality.
  • Effective management necessitates accurate classification of the effusion's stage.

Purpose of the Study:

  • To review current diagnostic and therapeutic strategies for parapneumonic effusions.
  • To provide guidelines for managing different stages of parapneumonic effusions and empyemas.
  • To aid clinicians in selecting optimal treatment based on effusion characteristics.

Main Methods:

  • Literature review of diagnostic modalities for pleural effusions.
  • Analysis of therapeutic interventions for parapneumonic effusions and empyemas.

Related Experiment Videos

  • Synthesis of current guidelines for managing complicated and uncomplicated effusions.

    • Main Results:

    • Parapneumonic effusions are categorized into exudative, fibropurulent, or organizational stages.
    • Treatment approaches range from conservative management to aggressive surgical intervention.
    • Timely and accurate staging is crucial for predicting effusion course.

    Conclusions:

    • Effective management of parapneumonic effusions depends on accurate staging.
    • A spectrum of therapeutic options exists, tailored to the effusion's stage and complexity.
    • Guidelines are essential for optimizing treatment and improving patient outcomes in parapneumonic effusions and empyemas.